Today at MEDS
Clinician Reviews and the Primary Care Metabolic Group welcomed more than 300 NPs, PAs, RNs, CDEs, and other clinicians involved in the diagnosis and management of metabolic and endocrine disorders from across the United States and abroad to the 2018 Metabolic and Endocrine Disease Summit (MEDS). This annual conference, headed by Meeting Chair Scott Urquhart, PA-C, DFAAPA, and Co-Chair Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP, was held August 1-4, 2018, at the Wyndham San Diego Bayside in San Diego, California, providing the opportunity for attendees to earn up to 24.25 CE/CME credits.
View summaries from the event on the following pages.
Men’s and Women’s Health Issues and Endocrine Disease
Ji Hyun (CJ) Chun, PA-C, MPAS, BC-ADM, American Society of Endocrine PAs, and R. Mimi Secor, DNP, FNP-BC, FAANP, Nurse Practitioner Associates for Continuing Education
Chun and Secor reviewed the physiology and pathophysiology of male hypogonadism, the elements of a comprehensive diagnostic protocol, and appropriate monitoring of patients taking testosterone replacement therapy (TRT). They said that differentiating organic hypogonadism and late-onset hypogonadism (LOH) is of utmost importance to prevent long-term complications of true hypogonadism. While the benefits of treatment clearly outweigh the risks for patients with organic hypogonadism, the benefit-risk ratio for patients with LOH is unclear.
